文献速递贫血与红细胞疾病

人血清红细胞铁调节蛋白的免疫测定方法

Immunoassay for human serum erythroferrone.
PubMed 文献 · Blood · 2017-07-24

红细胞铁调节蛋白(ERFE)是由红系祖细胞在促红细胞生成素(EPO)刺激下分泌的糖蛋白激素。本研究开发并验证了基于兔单克隆抗体的夹心免疫测定法,用于检测人血清ERFE,并显示失血或EPO给药可升高人血清ERFE浓度,未输血和输血依赖型β-地中海贫血患者血清ERFE水平很高,输血后下降。

要点

  • 开发并技术验证了兔单克隆抗体夹心免疫测定法检测人血清ERFE。
  • 失血或EPO给药可升高人血清ERFE浓度。
  • 未输血和输血依赖型β-地中海贫血患者血清ERFE水平很高,输血后下降。

核心结论

  • 该免疫测定法应可用于人类正常和异常红细胞生成及其对铁稳态影响的研究。

研究设计与样本

  • 开发并技术验证了基于兔单克隆抗体的夹心免疫测定法,用于检测人血清ERFE,未报告样本量。

主要发现

  • 失血或EPO给药可升高人血清ERFE浓度。
  • 未输血和输血依赖型β-地中海贫血患者血清ERFE水平很高。
  • 输血后β-地中海贫血患者血清ERFE水平下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Erythroferrone (ERFE) is a glycoprotein hormone secreted by erythroblasts in response to stimulation by erythropoietin (EPO). We previously demonstrated that ERFE messenger RNA expression and serum protein concentration increase in mice subjected to hemorrhage or EPO therapy, that ERFE acts on hepatocytes to suppress hepcidin, and that the resulting decrease in hepcidin augments iron delivery for intensified erythropoiesis. We also showed that ERFE contributes to pathological hepcidin suppression and iron overload in mice with nontransfused β-thalassemia. We now report the development and technical validation of a rabbit monoclonal antibody-based sandwich immunoassay for human ERFE. We use this assay to show that blood loss or EPO administration increases serum ERFE concentrations in humans, and that patients with both nontransfused and transfused β-thalassemia have very high serum ERFE levels, which decrease after blood transfusion. The assay should be useful for human studies of normal and disordered erythropoiesis and its effect on iron homeostasis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Ganz T, Jung G, Naeim A, et al. Immunoassay for human serum erythroferrone. Blood. 2017. PMID: 28739636. doi:10.1182/blood-2017-04-777987

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。